Al-rafidain Journal of Medical Sciences

OCT 19, 2026 · JOURNAL ARTICLE

Claudin-6 (CLDN6) and Folate Receptor Alpha (FRα) Targeted Antibody-Drug Conjugates: Bypassing Platinum Resistance and Tumor Heterogeneity in High-Grade Serous Ovarian Carcinoma

Al-rafidain Journal of Medical Sciences

High-grade serous ovarian carcinoma (HGSOC) is the most lethal gynecologic malignancy, and predicting its outcomes is complicated by two interlinked adversaries: the near-inevitabl

OCT 16, 2026 · JOURNAL ARTICLE

Frailty and Fatigue in the Elderly Cancer Patients at Wasit Specialized Oncology Center, Wasit, Iraq

Al-rafidain Journal of Medical Sciences

Background: Cancer is a general term for a big group of diseases that affect many systems of the human body. Incessant fatigue was recorded as the most frequent continuing symptom,

OCT 14, 2026 · JOURNAL ARTICLE

The Role of Non-Coding RNAs in Chemoresistance to Cancer Therapies

Al-rafidain Journal of Medical Sciences

Chemoresistance remains one of the greatest challenges in modern oncology and is responsible for most cancer-related deaths. Growing evidence has identified non-coding RNAs (ncRNAs

OCT 6, 2026 · JOURNAL ARTICLE

Sarcopenia and Its Associated Factors among Urban Sedentary Adults in Jakarta: Evidence from a Large Multidistrict Dataset

Al-rafidain Journal of Medical Sciences

Background: Sarcopenia is a major public health concern in aging populations, particularly in urban sedentary settings, where physical inactivity and metabolic disorders contribute

AUG 7, 2026 · JOURNAL ARTICLE

Prevalence, Risk Factors, and Management of Gestational Diabetes Mellitus in Guelma City (East Algeria): A Cross-Sectional Study

Al-rafidain Journal of Medical Sciences

Single-centre cross-sectional descriptive study of prevalence and risk factors in a specific geographic population; no comparator, no randomization, and no causal inference possible from the design.